The Wall Street Journal, January 29, 2020. New FDA Commissioner Stephen Hahn faces tug of war over controversial issues in health, including e-cigarettes, stem-cell research, and the use of cannabidiol (CBD).
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Everything is designed for men, even drugs
Vox, January 16, 2020. Designing medicine around the “average man” is so dangerous. We need more inclusivity in clinical trials — for women, for people over 65, and for people of color.
Read More »FDA’s tech overhaul is underway
Politico, January 14, 2020. The FDA is reviewing a handful of pain medications, including some new opioids, as the country continues to struggle with misuse and addiction to narcotics.
Read More »Device warning letters plunged nearly 90% over 5 years. An FDA official predicts a rebound
MedTech Dive, January 10, 2020. FDA warning letters to medical device manufacturers slid by nearly 90% between 2015 and 2019, but may be set to rebound upward in 2020.
Read More »Schools Seek Ways to Curb Vaping Among Students
The Wall Street Journal, January 6, 2020. With the rise of vaping related illnesses, schools turn to new tactics to deter students from vaping.
Read More »